Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients.
Satyendra Kumar SonkarPrashant Kumar SinghSharad ChandraGyanendra Kumar SonkarVivek BhosaleSharad SharmaPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2022)
These findings suggest that serum Cat S might be useful as an early biomarker for CVD in CKD patients.